Cuiting Zheng
Overview
Explore the profile of Cuiting Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lv J, Wang Y, Lv J, Zheng C, Zhang X, Wan L, et al.
Cell Death Dis
. 2025 Jan;
16(1):42.
PMID: 39863613
TSC2, a suppressor of mTOR, is inactivated in up to 20% of HBV-associated liver cancer. This subtype of liver cancer is associated with aggressive behavior and early recurrence after hepatectomy....
2.
Gao Z, Zheng C, Xing Y, Zhang X, Bai Y, Chen C, et al.
Int Immunopharmacol
. 2023 Oct;
125(Pt A):111074.
PMID: 37879229
Sepsis-induced myocardial dysfunction (SIMD) is the main cause of mortality in sepsis. In this study, we identified Polo-like kinase 1 (Plk-1) is a promoter of SIMD. Plk-1 expression was increased...
3.
Chen R, Wang H, Zheng C, Zhang X, Li L, Wang S, et al.
Respir Res
. 2023 Aug;
24(1):204.
PMID: 37598171
Background: Pulmonary hypertension (PH) is a lethal vascular disease with limited therapeutic options. The mechanistic connections between alveolar hypoxia and PH are not well understood. The aim of this study...
4.
Chen C, Zhang X, Zheng C, Gao Z, Jiang X, Bai Y, et al.
Clin Exp Pharmacol Physiol
. 2022 May;
49(7):776-783.
PMID: 35538895
A thorough understanding of the pathological process underlying hypertension-induced cardiac remodelling may help in prevention and treatment of heart failure. Angiotensin II (AngII) results in cardiac fibrosis and hypertrophy partly...
5.
Zhang X, Zheng C, Gao Z, Wang L, Chen C, Zheng Y, et al.
J Cell Mol Med
. 2021 Oct;
25(22):10711-10723.
PMID: 34687136
Hypertensive cardiac remodelling is a common cause of heart failure. However, the molecular mechanisms regulating cardiac remodelling remain unclear. Pyruvate kinase isozyme type M2 (PKM2) is a key regulator of...
6.
Zhang X, Zheng C, Gao Z, Chen H, Li K, Wang L, et al.
Cardiovasc Drugs Ther
. 2021 Jul;
36(3):437-447.
PMID: 34259984
Purpose: Systemic hypertension may induce adverse hypertrophy of the left cardiac ventricle. Pathological cardiac hypertrophy is a common cause of heart failure. We investigated the significance of ferroptosis repressor xCT...